-
S-Ruxolitinib (INCB018424
S-Ruxolitinib is the chirality of INCB018424, which is the first potent, selective, JAK1/2
-
WHI-P154
-
Ruxolitinib (INCB018424
-
(3S,4R)-Tofacitinib
-
JANEX-1
-
NVP-BSK805 2HCl
2HCl是一种有效的,选择性的,ATP竞争性的JAK2抑制剂,IC50为0.5 nM,比作用于JAK1, JAK3和TYK2选择性高20倍以上
-
CEP-33779
-
Mubritinib (TAK 165
-
(3S,4S)-Tofacitinib
-
(3R,4S)-Tofacitinib
Tofacitinib(CP-690550)是高效JAK3抑制剂,IC50为1 nM,比对JAK2和JAK1的抑制性高20倍和100倍
想在此推广您的产品吗?
咨询热线: 010-84839035
联系邮箱: sales@antpedia.net